• See Also
  1. Ulcerative Colitis
  • Indications
  1. Ulcerative Colitis
  • Contraindications
  1. Giazo is FDA approved for male patients only
  • Mechanism
  1. Diazo-Bonded 5-ASA product
    1. Oral agent converted to active 5-ASA (Mesalamine) by Bacteria within the colon
  • Dosing
  • Adult (and age>5 years)
  1. Colazal
    1. Start 2.25 g orally three times daily for 8 to 12 weeks
    2. Next 3 to 6 g/day divided three times daily
  2. Giazo (only male patients)
    1. Start 3.3 g orally twice daily for 8 weeks
  • Pharmacokinetics
  1. Minimal absorption
  • Efficacy
  1. Similar, but better tolerated (less Diarrhea) than Olsalazine
  • Safety
  1. Pregnancy Category B
  2. Unknown safety in Lactation
  • Resources
  1. Balsalazide-Colazal (DailyMed)
    1. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22f41e83-b9fb-4c9e-8cc3-f457034191a8
  • References
  1. (2022) Treatment of Mild to Moderate Ulcerative Colitis, Presc Lett, #350406
  2. (2023) Drugs for Inflammatory Bowel Disease, Med Lett Drug Ther 65: 105-12